Skip to content

Patient Controlled Propofol Sedation Versus Nurse-assisted Propofol Sedation in Diagnostic Colonoscopies With a Focus on Patient Satisfaction

Patient-Controlled Anesthesia for Endoscopic Procedural Sedation (PCAPS). A Randomized Controlled Trial Evaluating Patient-controlled Propofol Sedation in Diagnostic Colonoscopies

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07653867
Acronym
PCAPS1
Enrollment
135
Registered
2026-06-17
Start date
2026-11-01
Completion date
2028-11-01
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy (Procedure)

Keywords

colonoscopy, sedation, patient controlled propofol sedation

Brief summary

The goal of this clinical trial is to learn if patient administered propofol sedation results in superior patient satisfaction compared to nurse administered propofol sedation in diagnostic colonoscopies. • Does self administration of the sedative propofol increase patient satisfaction? Researchers will compare patient administered propofol sedation (where the patient administers propofol by pushing a button) with nurse administered propofol sedation (where a nurse gives the patient bolus doses of propofol as deemed necessary) Participants will: * Be randomized to either sedation route. * Answer a preendoscopy questioneere and a postendoscopy questioneere 1 hour after the examination as well as one week after the examination.

Interventions

DRUGSelf administred propofol

Patients will self administer propofol by pushing a button. When pushed a dose of 5 mg propofol will be given intravenously. The button can be pushed a maximum of 8 times per minute.

DRUGNurse assisted propofol sedation

The endoscopy nurse will administer bolus dosus of propofol (10 mg iv) as needed during the examination

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for elective diagnostic colonoscopy in propofol sedation * Able to understand the study information and provide inform consent * ASA I-II * Able to understand and use the patient-controlled sedation device * Able to complete study quistioneeres

Exclusion criteria

* ASA \>=III * Known hypersensitivity or contraindication to propofol or any excipient in the formulation. * Pregnancy or breastfeeding. * Inability to provide valid informed consent * Cognitive impairment, severe psychiatric illness, or other condition limiting reliable participation or questionnaire completion. * Inability to understand study procedures or insufficient language proficiency without available validated study support. * History of serious adverse reaction or complication related to sedation or anesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfactionOne hour after the examination and one week after the examinationPatient satisfaction measured using Patient satisfaction with sedation index (PSSI), a validated Likert-scale questionnaire with 13 questions. Each question with 5 ranks (1-5). Minimum score 13 , maximum score 65. Higher score indicates higher satisfaction with the sedation.

Secondary

MeasureTime frameDescription
Total propofol dose (mg)0 hours after examinationTotal given dose during the examination
Recovery time4 hours after the examinationTime to patient is ready for discharge. Patient will be assesed every 15 minutes until ready for discharge, maximum 4 hours
Procedure duration0 hours after examinationTime to completion of the procedure (min)
Adverse events30 daysAny adverse events related to sedation within 30 days

Countries

Sweden

Contacts

CONTACTRichard E Marsk, Docent
richard.marsk@ki.se+46 8 123 71956
PRINCIPAL_INVESTIGATORRichard E Marsk, Docent

Karolinska Institutet

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026